Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

278
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
278
Nephrons01:10

Nephrons

2.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.2K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

12.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

9.4K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
9.4K
The Electron Transport Chain01:30

The Electron Transport Chain

16.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Col003 attenuates sepsis-associated coagulation dysfunction in mice in association with reduced platelet activation and NET formation.

Thrombosis research·2026
Same author

Inhibition of MyD88 in Tubular Epithelial Cells Alleviates the Cellular Senescence in Sepsis-Associated Acute Kidney Injury.

Inflammation·2026
Same author

Targeting the renin-angiotensin system in sepsis-associated AKI: from pathophysiology to precision medicine.

Frontiers in immunology·2026
Same author

Establishment and validation of a machine learning-based prediction model for sepsis-induced coagulopathy.

Journal of thrombosis and thrombolysis·2026
Same author

Ulinastatin relieves sepsis-associated dysmotility via IL-1β-related enteric neuroprotection.

European journal of pharmacology·2026
Same author

The role of interleukin-4 in acute kidney injury and chronic kidney disease: a literature review.

BMC nephrology·2026

Related Experiment Video

Updated: Jun 15, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Mitochondrial dysfunction in acute kidney injury.

Congcong Yao1, Ziwei Li1, Keke Sun1

  • 1Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China.

Renal Failure
|August 28, 2024
PubMed
Summary
This summary is machine-generated.

Mitochondrial dysfunction drives acute kidney injury (AKI) pathogenesis by disrupting cellular quality control. Targeting these mitochondrial pathways offers a promising therapeutic strategy for improving patient outcomes in AKI.

Keywords:
Acute kidney injurymitochondrial biogenesismitochondrial dynamicsmitochondrial quality controlmitophagy

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.1K
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

8.8K

Related Experiment Videos

Last Updated: Jun 15, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.1K
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

8.8K

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) is a global health concern associated with high morbidity and mortality.
  • Renal tubular epithelial cell (TEC) death, driven by mitochondrial dysfunction, is a key factor in AKI development.
  • Imbalances in mitochondrial quality control mechanisms are central to this dysfunction.

Purpose of the Study:

  • To review recent advancements in understanding mitochondrial dysfunction in AKI.
  • To highlight the role of mitochondrial quality control in AKI pathogenesis.
  • To provide a foundation for developing targeted AKI therapies.

Main Methods:

  • Literature review of studies on mitochondrial dysfunction and AKI.
  • Analysis of mechanisms regulating mitochondrial integrity and function.
  • Synthesis of current research on therapeutic strategies targeting mitochondria in AKI.

Main Results:

  • Mitochondrial dysfunction, stemming from impaired quality control, significantly contributes to TEC death in AKI.
  • Key mitochondrial quality control processes include antioxidant defense, mtDNA repair, dynamics, mitophagy, and biogenesis.
  • Dysregulation of these processes exacerbates AKI pathology.

Conclusions:

  • Mitochondrial quality control is critical for maintaining renal tubular cell health and function during AKI.
  • Targeting mitochondrial dysfunction presents a viable therapeutic avenue for AKI.
  • Further research into these mechanisms can enhance clinical prevention and treatment strategies for AKI.